BALB/c mice immunized with graded doses of chromatographically purified hemagglutinin (HA) and neuraminidase (NA) antigens derived from A/Hong Kong/1/68 (H3N2) influenza virus demonstrated equivalent responses when HA-specific and NA-specific serum antibodies were measured by enzyme-linked immunosorbent assays (ELISAs). Antibody responses measured by hemagglutination inhibition or neuraminidase inhibition titrations showed similar kinetic patterns, except for more rapid decline in hemagglutination inhibition antibody. Injection of mice with either purified HA or NA resulted in immunity manifested by reduction in pulmonary virus following challenge with virus containing homologous antigens. However, the nature of the immunity induced by the two antigens differed markedly. While HA immunization with all but the lowest doses of antigen prevented manifest infection, immunization with NA was infection-permissive at all antigen doses, although reduction in pulmonary virus was proportional to the amount of antigen administered. The immunizing but infection-permissive effect of NA immunization over a wide range of doses is in accord with results of earlier studies with mice in which single doses of NA and antigenically hybrid viruses were used. The demonstrable immunogenicity of highly purified NA as a single glycoprotein without adjuvant offers a novel infection-permissive approach with potentially low toxicity for human immunization against influenza virus.
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Influenza A viruses contain two major virus-coded surface glycoproteins, the hemagglutinin (HA) and neuraminidase (NA), which are the antigens primarily involved in induction of specific humoral immunity to influenza virus. Earlier studies in which NA and HA were segregated in antigenically hybrid reassortant viruses (21, 35, 37) or that employed chemically isolated NA antigen (24, 36) established the different roles of the two viral proteins in the induction of immunity to influenza virus infection. Anti-NA antibody is infection permissive in that antibody against NA does not prevent infection (25, 36) . However, NA immunization can reduce viral replication below a pathogenic threshold so that infection can occur without apparent disease (2, 7, 25, 29) . Antibody against HA is generally neutralizing, presumably preventing infection by interfering with virus attachment to host cells (14) or possibly by interfering with the fusion event subsequent to endocytosis (20, 41) .
Vaccination with conventional, inactivated influenza virus vaccines, containing both HA and NA, stimulates immunity against both antigens (23) , although the immunologic response to NA is severely suppressed in primed subjects through HA-NA antigenic competition (17, 21) . Therefore, with biantigen vaccines, the effect of anti-HA immunity is overriding, and infection is usually prevented. However, the relative immunogenicity of NA can be increased in virusprimed humans (2, 5, 7, 21, 22) (16), NA-specific B cells, and the role of B-and T-cell collaboration in the intravirionic antigenic competition that results in immunodominance of one surface antigen over another (17) .
We have shown that differential priming of HA-and NA-specific B and T cells is involved in the antigenic competition between HA and NA (17) . This difference in priming ability could be due to the relatively greater molar amounts of HA than NA on the virion surface (9) or to intrinsic immunogenic differences between the two proteins. The present study compares the relative immunogenicity of influenza virus HA and NA in BALB/c mice injected with equivalent graded doses of purified H3 HA or N2 NA. Specific antibody response to each surface glycoprotein was evaluated by using reassortant viruses in hemagglutination inhibition (HI) and NA inhibition (NI) tests and purified antigens in enzyme-linked immunosorbent assays (ELISAs) and correlated with reduction of pulmonary virus levels in virus-infected mice.
MATERIALS AND METHODS
Viruses. The strains of influenza A viruses used in these studies are identified in (12) . After chromatography, individual fractions were dialyzed against sodium acetate buffer with 2 mM CaCl2 for 96 h to remove any residual detergent. Ca2+ in buffers stabilizes viral NA enzymatic activity (3, 8) and immunogenicity (E. D. Kilbourne, unpublished results ). Each fraction was tested for neuraminidase activity with fetuin substrate (1) and for hemagglutinating activity with chicken erythrocytes (31) . Fractions showing optimal activity were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis under nonreducing conditions by the method of O'Farrell (28) . Gels were silver stained by the method of Ohsawa and Ibata (30 NA or HA was used at 400 ng/ml in a volume of 100 ,ul per well. Antibody binding was detected by alkaline phosphatase-conjugated sheep anti-mouse immunoglobulin Gi (IgGl), IgG2a, IgG2b, IgG3, and IgM used at the manufacturer's recommended dilution (ICN Biomedical, Inc., Costa Mesa, Calif.).
Immunization. The study design and immunization protocol are outlined in Table 2 . A total of 180 BALB/c mice were randomly divided into two groups of 90 animals; each group received injections of either purified H3 HA or purified N2 NA. These two groups were further subdivided into nine subgroups of 10 animals, and each member of these subgroups received injections of antigen as indicated (Table 2) . Primary immune response to purified HA and NA. In both the H3 HA and N2 NA immunization protocols, 1 ,ug of purified antigen without adjuvant was administered i.p. 42 days following a control i.v. injection of steri!e PBS ( Table 2, group X). The 1-,ug doses of H3 HA and N2 NA induced equivalent but low levels of specific ELISA antibody, which peaked 14 days after injection (Fig. 2 ). There were no significant differences in HA and NA antigen-specific primary immune responses as measured by ELISA with respect to the maximum antibody titers induced or response kinetics. Measurements of antibody by HI or NI proved less sensitive. No NI antibody against N2 NA was found in any of the 10 mice injected with 1 ig of NA antigen (Fig. 3A) . Of the 10 mice injected with purified H3 HA, only 1 mouse had detectable levels of HI antibody against H3 (Fig. 3C ).
Secondary immune response to purified HA and NA. Data on secondary response are summarized graphically in Fig. 3 (Fig. 4) . Both of these groups had a significantly greater antibody response than the groups given 0.2 or 1 ,ug. However, when purified N2 NA was given with FCA, significant differences were VOL. 63, 1989 V.
- found between 5-,ug and 25-,ug groups as well as among groups given smaller doses.
The pattern of differences in H3 antibody measured by ELISA and HI tests in animals that received purified H3 was similar to that found with N2-immunized animals. The results of injections of 5 or 25 ,ug of H3 antigen given without FCA were not significantly different from each other but were significantly different from those for the 1.0-,ug and 0.2 ,ug groups. When FCA was included in the inoculum, significant differences (P > 0.0003) in ELISA (Fig. 4) and HI (Fig. 3) tests were found among all groups, with response proportional to antigen dose. The kinetics of HI and NI antibody responses differed. Although both glycoproteins induced significant rises in antibody titer from day 7 postboost to maximum titer levels on day 14, mice injected with N2 NA experienced a 15 to 39% decline in antibody titer by day 49 (Fig. 3) , whereas the decline from maximal HI titer in H3-immunized mice by that time ranged from 53 to 77%. However, these apparent differences in the rate of decline of HA and NA antibody were not as pronounced when antibodies were measured by ELISA. In N2-immunized mice, there was no significant difference between NA antibody measured by ELISA on days 14 and 49 (69 to 83% of the maximum titer was found on day 49). In comparison, H3 antibody titers were 53 to 87% of maximum titers by days 49, which represents a slightly significant difference (P > 0.076) between day 14 and day 49 ELISA antibody titers to HA. Furthermore, although NI antibody titers correlated highly with N2 antibody titers measured by ELISA (r = 0.94), the intensity of association between HI and H3 ELISA antibody was not as great (r = 0.63).
Infection in unimmunized mice. Infective virus was recovered from all 10 mice that had not been immunized with H3 HA or N2 NA antigens. Titration of pulmonary virus in each of these animals in MDCK cells gave a geometric mean endpoint titer of 1.53 x 10-8 PFU/ml of undiluted lung preparation.
H3N2 virus infection in N2-immunized mice. Consistent with past evidence that NA antibody is infection permissive (15, 25) , we found that all mice immunized with purified N2 NA were infected when challenged with H3N2 virus containing homologous NA. The occurrence of infection in these N2-primed mice was independent of N2 antibody concentrations, i.e., all mice were infected over a broad range of antibody levels (Fig. 5) . However, the concentration of infective virus decreased in direct proportion to preinfection levels of anti-N2 antibody (Fig. 6) . At the lowest N2 antibody level, reduction in pulmonary virus less than H3N2 virus infection in H3-immunized mice. Mice immunized with purified H3 HA had antibody titers comparable to those of N2-immunized animals. The HA and NA antibody titers of animals on the day of challenge infection are summarized in Fig. 3 and 4 . However, unlike N2 NA-primed animals, H3-immunized mice were susceptible to manifest infection only at relatively low HA antibody levels (HI, <1:4). Suppression of infection was evident at HI titers of only 1:8. Infection was not detected in animals with HI antibody titers greater than 1:16 (Fig. 5) .
As in the case of NI antibody, different levels of HI antibody were associated with proportional and reciprocal changes of pulmonary virus concentration (Fig. 6) . At the lowest HI antibody level, an approximately 2-fold reduction in pulmonary virus was observed, but a further 2-fold increase in HI titer was associated with an approximately 100-fold reduction in virus (Fig. 6 ). These curves (Fig. 6 ) demonstrate that HA immunization was infection permissive only in association with a low level of immunization, reflected in a very narrow antibody titer range. At most antibody levels, detectable infection was suppressed; in contrast, NA immunization, while associated with decreased virus levels, was infection permissive over a broad range of antibody concentrations.
DISCUSSION
In the present study we have shown that the influenza A virus surface glycoproteins HA and NA are equivalent immunogens in primary and secondary immune responses when equal amounts of these antigens are administered as purified proteins separated from other viral proteins. Injection of purified HA or NA induced identical maximum levels of specific antibody in ELISA tests (Fig. 4) . in immunogenicity, the antigenic competition between HA and NA that results in greater B-and T-cell priming to HA antigen (32) is most likely a manifestation of the greater molar amount of HA found on the virion surface and hence its presentation in greater amount to the antigen recognition elements of the immune system. This is consistent with one of the features of antigenic competition between mixed antigens, i.e., a marked dependence on the relative proportions of the antigens in the mixture. The direction and extent of antigen competition are influenced by the dose of the antigens (4) and their relative molar ratios (39) . Therefore, one way to avoid competition when mixed antigens are injected is to "balance" the mixture, i.e., adjust the proportions of the antigens so that competition does not occur. Such adjustment may assume particular importance when influenza virus vaccines are prepared for human use. Because there appear to be no intrinsic differences in the immunogenicity of HA and NA, balanced formulation of the two antigens might induce a more balanced anti-influenza virus response, avoiding the HA-skewed response to the presently available inactivated influenza virus vaccines (22) .
Was NA antibody response enhanced by small amounts of viral lipid in purified NA preparations? Earlier work has shown differences in the kinetics of primary response between antigen administered with adjuvant and antigen given without adjuvant (33) . As evidenced by the identical kinetics of primary response to purified NA and HA (Fig. 2) , the presence of some viral lipid in the NA preparation had no apparent effect on antibody response. This is consistent with observations suggesting that liposomal effects are not manifest on i.v. administration but depend on focal injection of antigen and lipid (11) . Also, it was shown recently that lipids enhance specific T-cell subclasses rather than antibody formation per se (6, 13) .
Although HA and NA induced equivalent levels of specific antibody and similar response kinetics in ELISA, some differences in antibody response curves were apparent when antibody responses to the two antigens were measured by NI or HI tests. However, using IgG and IgM isotype-specific reagents in the ELISA, similar patterns of response to HA and NA were found (data not shown). Measured by any method (ELISA, HI, or NI), antibody response to both HA and NA peaked 14 days after secondary antigenic stimulation. Thereafter, the degree of antibody decline varied in relationship to the immunizing antigen used (HA or NA) and the test used in the measurement of antibody. The trends observed for both increase and decline of antibody levels were essentially uninfluenced by the use of adjuvant except for the greater response in the adjuvant groups (Fig. 3) .
The sustained levels of ELISA antibodies seen with both antigens (Fig. 4) probably reflect both the greater accessibility of epitopes in that assay system and its lack of dependence on the biologic activity of the antigens to which antibody is measured. Thus, changes in antibody avidity might go undetected in a system that scores multivalent antibody to multiple antigenic sites. In contrast, both HI and NI tests depend on competition between antibody and either erythrocyte receptors or enzyme substrate for combination with virion antigens and, understandably, might be more susceptible to decline of high-avidity antibodies. In fact, the rate of decline was greatest (down to 20% of the peak) for HI antibody, while the difference between NI and NA ELISA titers at 49 days after boost was minimal. Even though the NI test measures the blocking of biologic (i.e., enzymatic) function, it may be more comparable to the ELISA in that it may measure a broad range of antibodies to different sites, any of which can act by steric hindrance to block enzymatic activity (10, 40) .
Challenge of mice immunized with isolated purified antigens confirms earlier evidence that NA-specific immunity is infection permissive over a broad range of antibody levels (2, 29, 35, 36) and that anti-HA immunity can prevent infection at relatively low antibody concentrations. That the effect of NA immunization may be mediated directly by circulating N2 antibody is suggested by previous evidence that passive administration of NA-specific antibody can ameliorate infection (36) .
Precise measurement of infectious virus present in immunized animals revealed critical differences between immunity induced by HA and NA. Immunization with purified HA in a wide range of doses prevented infection by virus bearing an antigenically homologous HA, a situation analogous to the immunity established by vaccination with conventional influenza virus vaccines. Purified N2 NA induced immunity similar to that seen after vaccination by antigenically hybrid (Fig. 7) .
The contrasting effects both in vitro and in vivo of antibodies to HA and NA proteins most likely reflect the different biologic roles that HA and NA play in the virus replication cycle, HA being essential to virus attachment and initiation of infection and NA being inhibitory to virus release (25) . The present study of purified surface antigens demonstrates that a cardinal element in establishing immunity to influenza virus is recognition of the surface glycoproteins of the virus. However, these findings do not negate the importance of cognate help in B-and T-cell interactions, in which humoral immune responses to HA or NA are supported by T cells that react with internal components of influenza virus (17, 32, 34) . After sequential H3N2 virus infection of mice, T cells from these animals proliferated equally in response to heterosubtypic (HlNl) influenza virus internal proteins but varied in their response to HA and NA (17) . The present study shows clearly that immunization with either antigen alone can alter the course of infection.
Most important, we have shown unequivocally that NA is not merely a weaker HA in its immunizing effect on virus replication but that the partial immunity it induces permits subsequent (further immunizing) infection to occur even at the highest level of immunity induced. Thus, immunization with purified NA offers a unique approach to the prevention of influenza. It is likely that as a single viral protein NA will have less toxicity than whole-virus vaccines, live or inactivated. As isolated from detergent-disrupted virus, NA is highly antigenic, and adjuvants, although demonstrably enhancing, should not be required for its use in humans. Finally, the slower rate of antigenic drift of NA in both HlNl (E. D. Kilbourne, unpublished data) and H3N2 (18) subtypes offers the prospect of longer-lasting immunity than that induced by the HA antigen or by conventional vaccines.
